Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients

Mismatch Repair Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy

(2020) Andrea Cercek et al.   CLINICAL CANCER RESEARCH

Modeling rectal cancer to advance neoadjuvant precision therapy

(2020) Harinarayanan Janakiraman et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic Potential of Lymphocyte–C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy

(2020) Yoshinaga Okugawa et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Applications of patient-derived tumor xenograft models and tumor organoids

(2020) Go J. Yoshida   Journal of Hematology & Oncology

Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma

(2020) Lorenzo Ferrando et al.   PLoS One

Locally advanced rectal cancer: The past, present, and future

(2020) Bryan Oronsky et al.   SEMINARS IN ONCOLOGY

Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer

(2020) Emilie Picard et al.   Frontiers in Immunology

The Effects of Neoadjuvant Treatment on the Tumor Microenvironment in Rectal Cancer: Implications for Immune Activation and Therapy Response

(2020) Chien-Chih Chen et al.   Clinical Colorectal Cancer

Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection

(2020) Katherine A. Johnson et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Gut microbiome composition is associated with a pathologic response after preoperative chemoradiation in rectal cancer patients

(2020) Bum-Sup Jang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

(2020) Te-Min Ke et al.   MEDICINE

High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy

(2020) Cheng-Yi Lin et al.   ONCOLOGY

Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem Cells

(2020) Xingru Li et al.   Cancers

Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors

(2020) Kasun Wanigasooriya et al.   Cancers

A diagnostic biopsy-adapted immunoscore predicts response to neoadjuvant treatment and selects patients with rectal cancer eligible for a watch-and-wait strategy

(2020) Carine El Sissy et al.   CLINICAL CANCER RESEARCH

The role of gut microbiota in cancer treatment: friend or foe?

(2020) Wing Yin Cheng et al.   GUT

Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer

(2020) Winnie Fong et al.   ONCOGENE

Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

(2020) Sinead Toomey et al.   Cancers

T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer

(2020) Takashi Akiyoshi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy

(2020) Hiroshi Miyakita et al.   ONCOLOGY

Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis

(2020) E. O'Connell et al.   SURGICAL ONCOLOGY-OXFORD

Comprehensive Analysis of DNA Methylation and Prediction of Response to NeoadjuvantTherapy in Locally Advanced Rectal Cancer

(2020) Luisa Matos do Canto et al.   Cancers

Prognostic Impact of the Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratio, in Patients with Rectal Cancer: A Retrospective Study of 1052 Patients

(2020) Zsolt Zoltán Fülöp et al.   Journal of Personalized Medicine

Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study

(2020) Yuxi Yi et al.   CLINICAL CANCER RESEARCH

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

(2020) Thierry André et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy

(2019) Tsung-Wei Chen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer

(2019) T. Akiyoshi et al.   BRITISH JOURNAL OF SURGERY

Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation

(2019) Cheri A. Pasch et al.   CLINICAL CANCER RESEARCH

β-Catenin/TCF4 Complex-Mediated Induction of the NRF3 (NFE2L3) Gene in Cancer Cells

(2019) Shiori Aono et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Liquid biopsy for rectal cancer: A systematic review

(2019) Daniela Massihnia et al.   CANCER TREATMENT REVIEWS

Epigenetic Biomarkers in Colorectal Cancer Patients Receiving Adjuvant or Neoadjuvant Therapy: A Systematic Review of Epidemiological Studies

(2019) Barchitta et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Lymph node number, surface area and lymph node ratio are important prognostic indicators in neoadjuvant chemoradiotherapy treated rectal cancer

(2019) Francesca Pitto et al.   JOURNAL OF CLINICAL PATHOLOGY

MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4

(2019) Huyen Trang Ha Thi et al.   NEOPLASIA

Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer

(2019) Ye Yao et al.   Cell Stem Cell

A rectal cancer organoid platform to study individual responses to chemoradiation

(2019) Karuna Ganesh et al.   NATURE MEDICINE

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients

(2019) Salo N. Ooft et al.   Science Translational Medicine

Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer

(2018) Shinji Matsutani et al.   CANCER SCIENCE

Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer

(2018) Atsushi Ogura et al.   EUROPEAN JOURNAL OF CANCER

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

(2018) Jeanne Tie et al.   GUT

Impact of RAS/BRAF mutation status in locally advanced rectal cancer treated with preoperative chemotherapy

(2018) Taihei Oshiro et al.   International Journal of Clinical Oncology

Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection

(2018) Giuseppe Portale et al.   JOURNAL OF GASTROINTESTINAL SURGERY

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

(2018) Franck Pagès et al.   LANCET

A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers

(2018) You Guo et al.   RADIOTHERAPY AND ONCOLOGY

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

(2018) Georgios Vlachogiannis et al.   SCIENCE

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

(2018) Krijn K. Dijkstra et al.   CELL

Intra-tumour diversification in colorectal cancer at the single-cell level

(2018) Sophie F. Roerink et al.   NATURE

C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy

(2018) Woo Ram Kim et al.   ANNALS OF SURGICAL ONCOLOGY

Organoid Modeling of the Tumor Immune Microenvironment

(2018) James T. Neal et al.   CELL

Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids

(2018) Ryan C. Smith et al.   Cell Stem Cell

LncRNA and mRNA signatures associated with neoadjuvant chemoradiotherapy downstaging effects in rectal cancer

(2018) Ning Li et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer

(2018) Marc Campayo et al.   PLoS One

Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy

(2018) Dengbo Ji et al.   Cancer Immunology Research

Patient-derived organoids: a promising model for personalized cancer treatment

(2018) Huayu Yang et al.   Gastroenterology Report

Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer

(2018) Shaakir Hasan et al.   ANNALS OF SURGERY

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer

(2017) Delphine Dayde et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Molecular profiling of locally-advanced rectal adenocarcinoma using microRNA expression (Review)

(2017) Cory Pettit et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8 + Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis

(2017) Yu Jin Lim et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Modeling of Patient-Derived Xenografts in Colorectal Cancer

(2017) Anastasia Katsiampoura et al.   MOLECULAR CANCER THERAPEUTICS

Cytokines in Cancer Immunotherapy

(2017) Thomas A. Waldmann   Cold Spring Harbor Perspectives in Biology

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

(2017) Moritz Schütte et al.   Nature Communications

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response

(2017) Melanie J. McCoy et al.   Oncotarget

Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer

(2017) Alba Cristobal et al.   Cell Reports

Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer

(2017) Armin Jarosch et al.   OncoImmunology

Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study

(2017) C. Mirjolet et al.   OncoImmunology

KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy

(2016) Oliver S. Chow et al.   ANNALS OF SURGICAL ONCOLOGY

The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer

(2016) Stephan B. Dreyer et al.   ANNALS OF SURGICAL ONCOLOGY

Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma

(2016) Damiano Caputo et al.   CANCER INVESTIGATION

Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review

(2016) J. E. Ryan et al.   Colorectal Disease

PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis

(2016) Markus Hecht et al.   EUROPEAN JOURNAL OF CANCER

DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics

(2016) Nicole de Rosa et al.   JOURNAL OF CLINICAL ONCOLOGY

Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

(2016) Takuro Saito et al.   NATURE MEDICINE

Neoadjuvant therapy does not affect lymph node ratio in rectal cancer

(2016) K.H. Chang et al.   SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND

Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy

(2016) Wenjie Sun et al.   Oncotarget

Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity

(2016) Rebecca Posselt et al.   Oncotarget

Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis

(2016) Yong-Jing Yang et al.   Oncotarget

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

(2016) Carla S Verissimo et al.   eLife

Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer

(2016) Xiaobin Gu et al.   PLoS One

Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer

(2015) Woo Jin Choi et al.   ANNALS OF SURGICAL ONCOLOGY

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer

(2015) M J McCoy et al.   BRITISH JOURNAL OF CANCER

The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy

(2015) Xue Dou et al.   Cancer Biomarkers

Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data

(2015) M. Nunes et al.   CANCER RESEARCH

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

(2015) Marc van de Wetering et al.   CELL

High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer

(2015) L. Flanagan et al.   Radiation Oncology

A phase I–II study on the combination of rapamycin and short course radiotherapy in rectal cancer

(2015) Jeroen Buijsen et al.   RADIOTHERAPY AND ONCOLOGY

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

Cell viability assessment using the Alamar blue assay: A comparison of 2D and 3D cell culture models

(2015) F. Bonnier et al.   TOXICOLOGY IN VITRO

Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte–associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer

(2015) Feifei Teng et al.   Translational Research

Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer

(2015) Camila Lopes-Ramos et al.   Cancer Genetics

Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patients

(2015) Bo Young Oh et al.   Oncotarget

Review of the development of DNA methylation as a marker of response to neoadjuvant therapy and outcomes in rectal cancer

(2015) Jeremy S. Williamson et al.   Clinical Epigenetics

Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions

(2015) Kazuko Sakai et al.   Oncotarget

CD8+ and FOXP3+ Tumor-Infiltrating T Cells Before and After Chemoradiotherapy for Rectal Cancer

(2014) Eiji Shinto et al.   ANNALS OF SURGICAL ONCOLOGY

Lymph Node Ratio is an Independent Prognostic Factor in Node Positive Rectal Cancer Patients Treated with Preoperative Chemoradiotherapy Followed by Curative Resection

(2014) Wei-Gen Zeng et al.   Asian Pacific Journal of Cancer Prevention

Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer

(2014) M.-G. Anitei et al.   CLINICAL CANCER RESEARCH

Detection of circulating tumor cells in patients with locally advanced rectal cancer undergoing neoadjuvant therapy followed by curative surgery

(2014) Elena Magni et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway

(2014) GUANGYU WANG et al.   ONCOLOGY REPORTS

Expression Profiling of Rectal Tumors Defines Response to Neoadjuvant Treatment Related Genes

(2014) Pablo Palma et al.   PLoS One

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints

(2014) Nicolas J. Llosa et al.   Cancer Discovery

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

(2014) M. Hidalgo et al.   Cancer Discovery

Mutations in Specific Codons of the KRAS Oncogene are Associated with Variable Resistance to Neoadjuvant Chemoradiation Therapy in Patients with Rectal Adenocarcinoma

(2013) Marjun P. Duldulao et al.   ANNALS OF SURGICAL ONCOLOGY

Gene expression profile is associated with chemoradiation resistance in rectal cancer

(2013) G. A. Gantt et al.   Colorectal Disease

Prediction of Response to Preoperative Chemoradiotherapy in Rectal Cancer by Using Reverse Transcriptase Polymerase Chain Reaction Analysis of Four Genes

(2013) Toshiaki Watanabe et al.   DISEASES OF THE COLON & RECTUM

The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer

(2013) Wenjie Sun et al.   Future Oncology

Gene methylation in rectal cancer: Predictive marker of response to chemoradiotherapy?

(2013) Chiara Molinari et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Radiotherapy Response in Microsatellite Instability Related Rectal Cancer

(2013) Joo-Shik Shin et al.   Korean Journal of Pathology

The role of plasma cell-free DNA detection in predicting preoperative chemoradiotherapy response in rectal cancer patients

(2013) W. SUN et al.   ONCOLOGY REPORTS

Changes in the plasma levels of cytokines/chemokines for predicting the response to chemoradiation therapy in rectal cancer patients

(2013) NORIKO TADA et al.   ONCOLOGY REPORTS

AlgiMatrix™ Based 3D Cell Culture System as an In-Vitro Tumor Model for Anticancer Studies

(2013) Chandraiah Godugu et al.   PLoS One

Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery

(2013) Kai-Lin Yang et al.   Radiation Oncology

KRAS mutation does not predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis

(2013) Cillian Clancy et al.   SURGICAL ONCOLOGY-OXFORD

Evaluating cell lines as tumour models by comparison of genomic profiles

(2013) Silvia Domcke et al.   Nature Communications

Elevated CEA Levels and Low Distance of the Tumor from the Anal Verge are Predictors of Incomplete Response to Chemoradiation in Patients with Rectal Cancer

(2012) Angelo Restivo et al.   ANNALS OF SURGICAL ONCOLOGY

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

P53 Status as a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer

(2012) Min-Bin Chen et al.   PLoS One

Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy

(2011) Emil Kendziorra et al.   CARCINOGENESIS

Pretreatment Transcriptional Profiling for Predicting Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma

(2011) K. H. Brettingham-Moore et al.   CLINICAL CANCER RESEARCH

The Role of Carcinoembriogenic Antigen in Predicting Response and Survival to Neoadjuvant Chemoradiotherapy for Distal Rectal Cancer

(2011) Rodrigo O. Perez et al.   DISEASES OF THE COLON & RECTUM

Complete Clinical Response After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Characterization of Clinical and Endoscopic Findings for Standardization

(2011) Angelita Habr-Gama et al.   DISEASES OF THE COLON & RECTUM

The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer

(2011) Sung Pil Hong et al.   EUROPEAN JOURNAL OF CANCER

Molecular Diagnosis of Response to Neoadjuvant Chemoradiation Therapy in Patients with Locally Advanced Rectal Cancer

(2011) Zhenbin Chen et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

(2011) J.-P. Gillet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer

(2011) Koji Yasuda et al.   Radiation Oncology

Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy

(2011) Janine M Davies et al.   Radiation Oncology

5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency

(2010) K Bracht et al.   BRITISH JOURNAL OF CANCER

3D collagen type I matrix inhibits the antimigratory effect of doxorubicin

(2010) Emilie Millerot-Serrurot et al.   Cancer Cell International

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

(2010) Nobuyoshi Kosaka et al.   CANCER SCIENCE

Gene Expression Profiles of Epidermal Growth Factor Receptor, Vascular Endothelial Growth Factor and Hypoxia-inducible Factor-1 with Special Reference to Local Responsiveness to Neoadjuvant Chemoradiotherapy and Disease Recurrence After Rectal Cancer Surgery

(2010) Y. Toiyama et al.   CLINICAL ONCOLOGY

Predictive Factors of Tumor Response After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

(2010) Laurence Moureau-Zabotto et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

KRAS and BRAF Mutations and PTEN Expression Do Not Predict Efficacy of Cetuximab-Based Chemoradiotherapy in Locally Advanced Rectal Cancer

(2010) Philipp Erben et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Microsatellite instability and survival in rectal cancer

(2009) Wade S. Samowitz et al.   CANCER CAUSES & CONTROL

Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy

(2009) V. Moreno García et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

(2009) TAEK-KEUN NAM et al.   Oncology Letters

Microarray-Based Prediction of Tumor Response to Neoadjuvant Radiochemotherapy of Patients With Locally Advanced Rectal Cancer

(2008) Caroline Rimkus et al.   Clinical Gastroenterology and Hepatology

Carcinoembryonic Antigen as a Predictor of Pathologic Response and a Prognostic Factor in Locally Advanced Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy and Surgery

(2008) Ji Won Park et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

(2008) Paul Salama et al.   JOURNAL OF CLINICAL ONCOLOGY

Accuracy of Endorectal Ultrasonography and Computed Tomography for Restaging Rectal Cancer after Preoperative Chemoradiation

(2008) Jung Wook Huh et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS